Taiwania Capital Joins Pool of Existing Investors to Fund $17 Million of Series B-1 Investment in Novel Drug Delivery Company, Windgap Medical, Inc.
Windgap is working closely with investors who plan to participate in a second close within the next ninety days, targeting an additional $15 million of investment.
For the full press release click here.